药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
Temefos
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Temefos.
4-Bromo-2,5-dimethoxyamphetamine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Delafloxacin.